Buteyko method for people with asthma: a protocol for a systematic review and meta-analysis

Author:

Mendonça Karla Morganna Pereira Pinto de,Collins Sean,Santos Tácito ZM,Chaves Gabriela,Leite Sarah,Santino Thayla AmorimORCID,Monteiro Karolinne SouzaORCID

Abstract

IntroductionButeyko method is recommended as a non-pharmacological treatment for people with asthma. Although the worldwide interest in the Buteyko method, there is a paucity of studies gathering evidence to support its use. Therefore, we aim to conduct a systematic review and meta-analysis to assess the effects of the Buteyko method in children and adults with asthma.Methods and analysisWe will search on Cochrane Central Register of Controlled Trials, MEDLINE, Embase, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov and WHO International Clinical Trials Registry Platform for studies focusing on the Buteyko method for children and adults with asthma. The searches will be carried out in September 2021 from database’s inception to the present. We will include randomised controlled trials comparing Buteyko method alone with asthma education or inactive control intervention. There will be no restriction on language. Primary outcomes include quality of life, asthma symptoms and adverse events/side effects. Two review authors will independently screen the studies for inclusion and extract data. We will assess the quality of the included studies using the ‘Risk of Bias’ tool. The certainty of the evidence will be assessed using the GRADE approach. Data synthesis will be conducted using Review Manager software. Reporting of the review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance and the Cochrane Handbook for Systematic Reviews of Interventions.Ethics and disseminationThis study will assess and provide evidence for the use of the Buteyko method in people with asthma. We will analyse secondary data and this does not require ethics approval. The findings will be published in peer-reviewed journals, at relevant conferences and will be shared in plain language in social media. Moreover, the findings of this review could guide the direction of healthcare practice and research.PROSPERO registration numberCRD42020193132.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Universidade Federal do Rio Grande do Norte

Publisher

BMJ

Subject

General Medicine

Reference28 articles.

1. Epidemiology of asthma and influence of ethnicity;Moraes;Semin Respir Crit Care Med,2018

2. Global Initiative for Asthma (GINA) . Global strategy for asthma management and prevention 2020, 2020. Available: ginasthma.org/gina-reports/ [Accessed 30 Dec 2020].

3. World Health Organization (WHO) . Asthma, 2020. Available: www.who.int/news-room/fact-sheets/detail/asthma [Accessed 5 Jan 2021].

4. Physiotherapy breathing retraining for asthma: a randomised controlled trial;Bruton;Lancet Respir Med,2018

5. British Thoracic Society (BTS) . SIGN 158 British guideline on the management of asthma: a national clinical guideline. Available: www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/ [Accessed 5 Jan 2021].

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3